Logo Image

Shorts

Plasma Biomarkers Match CSF Performance in Early Alzheimer Disease
1:19
Plasma Biomarkers Match CSF Performance in Early Alzheimer Disease
2 months ago
by
Thomas Wisniewski, MD(+1 more)
RECAP: Neurology News Network - Week of August 8th
1:21
RECAP: Neurology News Network - Week of August 8th
2 months ago
by
Louie Pasculli
What Advantages Does THUNDERBOLT Offer? | Part 2
1:03
What Advantages Does THUNDERBOLT Offer? | Part 2
2 months ago
by
Young Lee, MD(+1 more)
The Gut-Brain Connection in Parkinson Disease
1:06
The Gut-Brain Connection in Parkinson Disease
2 months ago
by
Laurie Sanders, PhD(+1 more)
Future Genetic Therapies Poised to Shape PNS 2027
2:07
Future Genetic Therapies Poised to Shape PNS 2027
2 months ago
by
Brian Callaghan, MD, MS
What Advantages Does THUNDERBOLT Offer? | Part 1
1:07
What Advantages Does THUNDERBOLT Offer? | Part 1
2 months ago
by
Young Lee, MD(+1 more)
Why Nerve Pain Lingers After Injury
0:42
Why Nerve Pain Lingers After Injury
2 months ago
by
Mitzi Joi Williams, MD
Key Factors Driving Treatment Selection in Generalized Myasthenia Gravis
1:29
Key Factors Driving Treatment Selection in Generalized Myasthenia Gravis
2 months ago
by
Miriam Freimer, MD(+1 more)
RECAP: Neurology News Network - Week of August 1st
1:45
RECAP: Neurology News Network - Week of August 1st
2 months ago
by
Louie Pasculli
Navigating Drug Selection and Combination Therapy in gMG
1:29
Navigating Drug Selection and Combination Therapy in gMG
2 months ago
by
Miriam Freimer, MD(+1 more)
Understanding Nerve Pain vs. Joint Pain
1:09
Understanding Nerve Pain vs. Joint Pain
2 months ago
by
Mitzi Joi Williams, MD
AAIC 2026: Trontinemab and the Brainshuttle Technology
1:26
AAIC 2026: Trontinemab and the Brainshuttle Technology
3 months ago
by
Geoff Kerchner, MD, PhD(+1 more)
CMSC 2026: Assessing Biological Disease Activity in MS
1:08
CMSC 2026: Assessing Biological Disease Activity in MS
3 months ago
by
Darin T. Okuda, MD, FAAN, FANA(+1 more)
AAIC 2026: Future of Blood-Based Biomarkers for Alzheimer Care
1:26
AAIC 2026: Future of Blood-Based Biomarkers for Alzheimer Care
3 months ago
by
Soeren Mattke, MD, DSc(+1 more)
AAIC 2026: Improving Amyloid Biomarker–Guided Diagnosis in AD
0:55
AAIC 2026: Improving Amyloid Biomarker–Guided Diagnosis in AD
3 months ago
by
Suzanne Schindler, MD, PhD(+1 more)
RECAP: Neurology News Network - Week of July 25th
2:02
RECAP: Neurology News Network - Week of July 25th
3 months ago
by
Louie Pasculli
Personalizing Communication About Emerging Alzheimer Disease Therapies
0:35
Personalizing Communication About Emerging Alzheimer Disease Therapies
3 months ago
by
Betty Tijms, PhD(+1 more)
Fragile X Syndrome Day 2026: 3 Primary Domains of Symptoms
1:07
Fragile X Syndrome Day 2026: 3 Primary Domains of Symptoms
3 months ago
by
Craig A. Erickson, MD(+1 more)
World Brain Day 2026: What is the Best Way to Preserve and Maintain Brain Health?
0:47
World Brain Day 2026: What is the Best Way to Preserve and Maintain Brain Health?
3 months ago
by
Jason A. Cohen, MD(+1 more)
AAIC 2026: Why Every “Shot on Goal” Matters in Alzheimer Disease Care
0:44
AAIC 2026: Why Every “Shot on Goal” Matters in Alzheimer Disease Care
3 months ago
by
Louie Pasculli(+1 more)
SLEEP 2026: Designing Phase 3 Trials for Narcolepsy Type 1
1:41
SLEEP 2026: Designing Phase 3 Trials for Narcolepsy Type 1
3 months ago
by
Elena Koundourakis, PhD(+1 more)
SLEEP 2026: Unmet Needs in Pediatric Sleep Medicine
1:13
SLEEP 2026: Unmet Needs in Pediatric Sleep Medicine
3 months ago
by
Carol Rosen, MD(+1 more)
AAIC 2026: Where Can Patients Learn About Emerging Alzheimer Disease Therapies?
0:41
AAIC 2026: Where Can Patients Learn About Emerging Alzheimer Disease Therapies?
3 months ago
by
Jeff Dage, PhD(+1 more)
SLEEP 2026: New Guidance on RLS Management
0:58
SLEEP 2026: New Guidance on RLS Management
3 months ago
by
Michael Silber, MBChB(+1 more)
Symptom Overlap Between Multiple Sclerosis and NMOSD
0:53
Symptom Overlap Between Multiple Sclerosis and NMOSD
3 months ago
by
Mitzi Joi Williams, MD
CMSC 2026: Questioning Targets in MS Treatment
0:50
CMSC 2026: Questioning Targets in MS Treatment
3 months ago
by
Ahmed Obeidat, MD, PhD(+1 more)
CMSC 2026: Enhancing MS Clinical Trial Impact
1:15
CMSC 2026: Enhancing MS Clinical Trial Impact
3 months ago
by
Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC(+1 more)
AAIC 2026: Rethinking Patient-Centered Neurology Care Today
0:40
AAIC 2026: Rethinking Patient-Centered Neurology Care Today
3 months ago
by
Mirnova Ceide, MD, MS(+1 more)
Expanding the Approach to AD Care Beyond Pharmacological Treatments
0:40
Expanding the Approach to AD Care Beyond Pharmacological Treatments
3 months ago
by
Elizabeth Rhodus, PhD, MS(+1 more)
RECAP: Neurology News Network - July 12th
0:58
RECAP: Neurology News Network - July 12th
3 months ago
by
Louie Pasculli